Statins are a class of hypolipidemic drugs, that are primarily used for the treatment of dyslipidemia and the prevention of cardiovascular disease. ATP III guidelines,2002, recommends that LDL cholesterol be the primary target of therapy, and lipid lowering therapy may be initiated based on evaluation of short term and long term cardiovascular risk(1). We are report a case of dysuria follow statin group of drugs, which is not enlisted in the side effect of these drugs. In the present case after re-challenge with similar group of drug patient again developed the symptoms. Underlying hyperlipidemia was effectively controlled with Fenofibrates.
Background: Tetanus is a vaccine-preventable disease that continues to occur despite several decades of sustained global health programs. Recently outbreaks of tetanus have been reported after natural disasters such as tsunamis and earthquakes.
Methods: The present study was carried out among 30 patients of tetanus irrespective of age, sex and severity, admitted in P.B.M. Hospital, Bikaner.
Results: Overall mortality was 30% in present study. Out of 10 patients in each group one in group I, 4 in group II and 4 in group III expired respectively. So the mortality was 10% in group I, 40% in group II & III. In mild tetanus mortality was nil in all groups. In moderate tetanus mortality was 9.9%. All patients of moderate tetanus in group I and II survived. In group III mortality in moderate tetanus patients was 20%. In severe tetanus patients over all mortality was 53.3%, in group I 25%, in group II and 50% and in group 10% respectively.
Conclusion- Intrathecal HTAT is safe and effective treatment.
Keywords: Intrathecal, Intravenous, Mortality, HTAT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.